InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Update

InnoCare Pharma Limited (OTCMKTS:INCPF) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 3,295,000 shares, a drop of 11.1% from the December 15th total of 3,707,000 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ? days.

InnoCare Pharma Price Performance

Shares of InnoCare Pharma stock opened at $3.26 on Friday. The business has a fifty day simple moving average of $3.26 and a 200-day simple moving average of $3.26. InnoCare Pharma has a 12 month low of $3.26 and a 12 month high of $3.72.

InnoCare Pharma Company Profile

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.